Clinical Trial Update: Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating steroid treatment to prevent rebound nasal obstruction after intranasal decongestant use was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Obstruction
• Rhinitis

Drugs mentioned

• Intranasal corticosteroids (intranasal corticosteroids)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Nasal Obstruction, Chronic Rhinitis | Phase 2 | Status: TERMINATED